Tweet
Sorry again Baoqing, I cannot answer this one. I am still working on getting the example from the publication to work, and I am trying to back everything up right now before I finish that.
-
-
Thanks a lot!
I will also keep working on mine and keep this post updated periodically.Comment
-
Ok, problem solved.
Two things need to be considered
1 when name your samples "alphabet+ numbers" always help！
2 In case of error, you need to delete cuffData.db in the folder before re-run it.Comment
-
What do you mean Baoqing when you say, "2. In case of error, you need to delete cuffData.db in the folder before re-run it."?
I didn't do #1 at first and had problems. So I re-ran the cuffdiff command with alphabet+numbers, and got the error message, "Error in .local(object, x, y, logMode, pseudocount, labels, smooth, ...) :"
What command do I use to "delete the cuffData.db"?
Thank you!Comment
-
Are you saying, delete cuffData.db in linux or R?Comment
-
Okay. Got it. I needed to delete the cuffData.db in linux before I ran the cuffdiff command again. Thank you.Comment
-
sorry for the late response. can you at least load the library?
i found that if you had tried to read your data before the library properly loaded, the generated cuffData.db is going to intervene your next new run. you can just going into the directory and delete it, i was using R in my ubuntu.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...Today, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment